en

PRODUCT DETAIL

TUKYSA 50 mg filmom obalené tablety

Code 6769D
MA number EU/1/20/1526/001
Product Form: tbl flm 88x50 mg (blis.OPA/PVC/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
L01EH03 Tucatinib
Shelf life: 24
Container: blister OPA/Al/PVC
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 11.02.2021
Validity: 11.02.2026
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 01.03.2021
eu-flag.png sk-flag.png